Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)-Reference-Cited by-同舟云学术

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)

Published:2007-01 Issue:1 Volume:18 Page:149-157
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Boehme V.,Zeynalova S.,Kloess M.,Loeffler M.,Kaiser U.,Pfreundschuh M.,Schmitz N.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/18/1/149/790682/mdl327.pdf

Reference29 articles.

1. CNS involvement in the non-Hodgkin's lymphomas;Levitt;Cancer,1980

2. Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis;Recht;Am J Med,1988

3. Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases;MacKintosh;Cancer,1982

4. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma;van Besien;Blood,1998

5. Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients;Haioun;Ann Oncol,2000

Cited by 236 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in CD5+ diffuse large B-cell lymphoma;Annals of Hematology;2024-08-28

2. Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis;Clinical Lymphoma Myeloma and Leukemia;2024-08

3. The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas;Blood Advances;2024-06-28

4. Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma;Leukemia;2024-05-15

5. Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy – a supplementary analysis of JCOG0601;Annals of Hematology;2024-01-27